Tuesday, July 7, 2009

Scrutiny on Two Continents for ‘Pay for Delay’

In Europe and the U.S., regulators are questioning the practice of paying generic manufacturers to delay competition for branded drugs.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)